Skip to content

MAKING BEST PRACTICE, EVERYDAY PRACTICE

FREE accredited digital CPD for health care professionals in South Africa

Accredited by the University of Pretoria

MAKING BEST PRACTICE, EVERYDAY PRACTICE

FREE accredited digital CPD for health care professionals in South Africa

Accredited by the University of Pretoria

Menu

Home
About
All clinical topics
SPECIAL INTEREST GROUPS
- Medical interns and registrars
Contact
ACCESS MY PROFILE

Menu

Home
About
All clinical topics
SPECIAL INTEREST GROUPS
- Medical interns and registrars
Contact
ACCESS MY PROFILE

[denovo_breadcrumbs]

Module 2: Vaccine-Preventable Pneumonia Series: Pneumococcal vaccination in populations at high risk

Questionnaire

To access this module, please register or login:

Login or Register

Module 2: Vaccine-Preventable Pneumonia Series: Pneumococcal vaccination in populations at high risk
Module 2: Vaccine-Preventable Pneumonia Series: Pneumococcal vaccination in populations at high risk

Time limit: 0

Questionnaire Summary

0 of 10 Questions completed

Questions:

Information

You have already completed the questionnaire before. Hence you can not start it again.

Questionnaire is loading…

You must sign in or sign up to start the questionnaire.

You must first complete the following:

Results

Questionnaire complete. Results are being recorded.

Results

0 of 10 Questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

Not categorized 0%

Regrettably, you have failed to achieve the 70% pass mark required by the accrediting HPCSA.
Please read/watch the module carefully and try once more!
(Only two tries are allowed)
Congratulations on successfully completing this FREE CPD module!
- For HPCSA members only: No need to load your certificate on HPCSA, as deNovo Medica uploads these weekly. Please allow 5-10 working days for the CPD activity to reflect on your HPCSA profile
- For non-HPCSA members: The above button allows you to download and print your CPD certificate to submit to your council yourself.
Please note you will no longer receive a pass confirmation email. Your activity automatically downloads on to your deNovo Medica profile.
Visit your profile HERE to find all your CPD certificates and activities completed.

1
2
3
4
5
6
7
8
9
10

Current
Review
Answered
Correct
Incorrect

Question 1 of 10
1. Question
1. The worldwide leading cause of morbidity and mortality related to lower respiratory tract infection is:
A. H. influenzae type b
Correct Incorrect Correct answer

B. S. pneumoniae
Correct Incorrect Correct answer

C. Influenza
Correct Incorrect Correct answer

D. RSV
Correct Incorrect Correct answer
Question 2 of 10
2. Question
2. Persons at elevated risk of IPD include:
A. Children aged <5 years, adults aged ≥65 years
Correct Incorrect Correct answer

B. Those with immunocompromise
Correct Incorrect Correct answer

C. Those with certain underlying comorbidities and lifestyle issues
Correct Incorrect Correct answer

D. All of the above
Correct Incorrect Correct answer

E. A and B only
Correct Incorrect Correct answer
Question 3 of 10
3. Question
3. Among general strategies to prevent pneumonia in children aged <5 years, the South African Thoracic Society recommends:
A. Vitamins A and D supplementation
Correct Incorrect Correct answer

B. Magnesium supplementation
Correct Incorrect Correct answer

C. Reduction of exposure to cigarette smoke and indoor fuels
Correct Incorrect Correct answer

D. All of the above
Correct Incorrect Correct answer

E. A and C only
Correct Incorrect Correct answer
Question 4 of 10
4. Question
4. To prevent pneumonia in children, PPSV23 is recommended at six weeks, 14 weeks and nine months of age.
A. True
Correct Incorrect Correct answer

B. False
Correct Incorrect Correct answer
Question 5 of 10
5. Question
5. For children living with HIV, other pneumonia preventive strategies additional to pneumococcal vaccination include:
A. Combination ARV therapy
Correct Incorrect Correct answer

B. Prophylaxis against pneumocystis pneumonia and tuberculosis
Correct Incorrect Correct answer

C. Prophylaxis against RSV and cytomegalovirus
Correct Incorrect Correct answer

D. All of the above
Correct Incorrect Correct answer

E. A and B only
Correct Incorrect Correct answer
Question 6 of 10
6. Question
6. PCV13 alone does not give adequate ST coverage for older South African adults.
A. True
Correct Incorrect Correct answer

B. False
Correct Incorrect Correct answer
Question 7 of 10
7. Question
7. The recommended interval between administering PCV13 and PPV23 in South Africa is:
A. One year for older adults with lower risk comorbidities
Correct Incorrect Correct answer

B. Six months for adults with high-risk immunocompromising conditions
Correct Incorrect Correct answer

C. Both of the above
Correct Incorrect Correct answer

D. None of the above
Correct Incorrect Correct answer
Question 8 of 10
8. Question
8. In adults with COPD, vaccination against pneumococcus alone has demonstrated:
A. Mortality benefit
Correct Incorrect Correct answer

B. Reductions in all-cause CAP
Correct Incorrect Correct answer

C. No reductions in exacerbations
Correct Incorrect Correct answer

D. All of the above
Correct Incorrect Correct answer

E. A and B only
Correct Incorrect Correct answer
Question 9 of 10
9. Question
9. In South Africa, PCV15 is indicated for active immunisation for the prevention of invasive disease, pneumonia, and acute otitis media caused by S. pneumoniae STs 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in:
A. Infants, children and adolescents aged between six weeks and prior to the 18th birthday
Correct Incorrect Correct answer

B. Adults aged 18 years and older
Correct Incorrect Correct answer

C. Both of the above
Correct Incorrect Correct answer

D. None of the above
Correct Incorrect Correct answer
Question 10 of 10
10. Question
10. Infants with gestational age <37 weeks:
A. Have a three-fold higher risk of IPD compared with full-term infants, with risk increasing with degree of prematurity
Correct Incorrect Correct answer

B. Should receive three doses of PCV during the primary series of childhood vaccinations
Correct Incorrect Correct answer

C. Demonstrated no vaccine-related severe AEs, discontinuations or deaths when receiving PCV15 or PCV13 in clinical trial settings
Correct Incorrect Correct answer

D. All of the above
Correct Incorrect Correct answer

All Rights Reserved 2025 © deNovo Medica (Pty) Ltd in South Africa. The content on this website is intended for healthcare related professionals unless stated otherwise.

Get involved

Become a sponsor Become a medical partner author/reviewer/society

Get involved

Become a sponsor Become a medical partner author/reviewer/society

Login

Accessing this module requires a login. Please enter your credentials below!

Username or Email Address

Password

Remember Me

Lost Your Password?